Decellularized vascular grafts
chapterposted on 2021-03-31, 10:02 authored by Ria Toumpaniari, Andres Hilfiker, Axel Haverich, Sotiris KorossisSotiris Korossis
Cardiovascular disease is one of the main causes of mortality and morbidity worldwide. The “gold standard” for the replacement/repair of diseased blood vessels is substitution with autologous vessels. However, multiple surgical procedures limit the availability of autologous vessels, whereas synthetic grafts have been reported to demonstrate poor patency rates, especially for small-caliber vascular reconstructions. Decellularization of native vascular or non-vascular tissues for vascular scaffold development has gained significant attention in the past 20 years. A variety of decellularization techniques have been described and employed to achieve effective immunogenic agent removal from the developed vascular scaffold. At the same time, the decellularization must not impair the extracellular matrix (ECM) composition, structure, and mechanical properties of the graft in order to ensure long-term functionality in vivo. The aim of this chapter was to review the various decellularization treatments that have been reported in the literature for the development of decellularized vascular scaffolds.
People Programme (Marie Curie Actions) of the EU 7th Framework Programme FP7/2007–2013/ under the TECAS-ITN (317512)
German Research Foundation through the Cluster of Excellence REBIRTH (EXC 62)
- Mechanical, Electrical and Manufacturing Engineering
Published inTissue-Engineered Vascular Grafts
Pages207 - 269
- AM (Accepted Manuscript)
Rights holder© Crown
Publisher statementThis book chapter was published in the book Tissue-Engineered Vascular Grafts [© Crown]. The final authenticated version is available online at: https://doi.org/10.1007/978-3-030-05336-9_8.
Book seriesReference Series in Biomedical Engineering